TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-09-04
公報種別公開国際商標公報
国際登録番号1798034
国際登録日2024-04-30
区分第1類(化学品),第5類(薬剤)
商品役務Active chemical ingredients for manufacture of fungicides, herbicides, insecticides, nematicides; chemical preparations for use in agriculture, horticulture and forestry; biological preparations for use in agriculture, horticulture and forestry; chemical preparations for seed treatment; organic seed-treatment preparations; adjuvants; soil fertilizers; fertilizing products.,Preparations for destroying vermin; fungicides, herbicides, insecticides, nematicides.
基礎出願番号06059/2024
基礎出願日2024-04-26
基礎出願国CH
出願人SYNGENTA CROP PROTECTION AG
OCRテキストTREVANCIA
OCRテキスト2TREVANCIA
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

BOPLAN BV
EXTRILENE
2か月前
BioAtlantis Limited
SuperFifty
3か月前
Migros-Genossenschafts-Bund
PHYTOCELLTEC
3か月前
Dr. Babor GmbH & Co. KG
BIOGEN
1か月前
AAA Oils & Fats Pte. Ltd
APICERINE
1か月前
Prof. Dr.-Ing. Wolfgang P. Weinhold
ABREX
1か月前
Miltenyi Biotec B.V. & Co. KG
RNAsky
1か月前
Global Amines Company Pte. Ltd.
GLOBALAMINES
1か月前
Rousselot B.V.
SIMOGEL
1か月前
L’OREAL
MICRO-BLUSHING TECHNOLOGY
1か月前
Glanbia Nutritionals Limited
ColostrumOne
1か月前
SAS WOODOO
WOODOO
1か月前
AAA Oils & Fats Pte. Ltd
APICID
1か月前
P2 Science, Inc.
CITROPOL
1か月前
Yankuang Lunan Chemicals Co., Ltd.
落田山 Luofengshan
1か月前
BGI SHENZHEN
1か月前
Bit Bio Limited
txCells
1か月前
Sartorius Lab Instruments GmbH & Co. KG
Cyclus
1か月前
Givaudan SA
OPTISPLASH
1か月前
Natac Biotech S.L.U.
FullSpectrum byNatac
1か月前
MOLSID
MICAST
1か月前
Shanghai Research Institute of Chemical Industry Co., Ltd
灏鹏
1か月前
Shanghai Research Institute of Chemical Industry Co., Ltd
HOPENE
1か月前
Sulzer Management AG
XPLA
1か月前
PromoCell GmbH
PromoExQ
1か月前
Barnet Products LLC
BARSPERSE
1か月前
Evonik Operations GmbH
VALMOCARE
1か月前
Jingliang LE
NianlidA
1か月前
BioLamina AB
Biolaminin
1か月前
AAA Oils & Fats Pte. Ltd
APISALT
1か月前
COSMAX, INC.
Xfine
1か月前
SAINT-GOBAIN WEBER
WEBERDRY
1か月前
INABATA FRANCE
INAWAVE
1か月前
BIOCOSMETHIC
INOSETHIC
1か月前
BIOCOSMETHIC
ACTIVESPHERES
1か月前
Meso Scale Diagnostics, LLC.
VS-PLEX
1か月前
続きを見る